# Nivolumab in Patients With Advanced Cutaneous Squamous Cell Carcinoma

> **NCT03834233** · PHASE2 · UNKNOWN · sponsor: **Instituto do Cancer do Estado de São Paulo** · enrollment: 24 (estimated)

## Conditions studied

- Advanced Cutaneous Squamous Cell Carcinoma

## Interventions

- **DRUG:** Nivolumab

## Key facts

- **NCT ID:** NCT03834233
- **Lead sponsor:** Instituto do Cancer do Estado de São Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-05
- **Primary completion:** 2019-12-01
- **Final completion:** 2022-12-01
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2020-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03834233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03834233, "Nivolumab in Patients With Advanced Cutaneous Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03834233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*